BrainCheck, a Houston, Texas-based digital neurocognitive testing platform, raised $1.5m in funding.
The round, which brought total funding to $6m to date, was led by True Wealth Ventures, with participation from Tensility Venture Partners, XFactor Ventures, S3 Ventures and angel investors.
The company intends to use the funds to use the capital to expand its R&D and enhance its offering and invest in sales and marketing talent to accelerate deployment in clinical practice.
Born at the Eagleman Neuroscience Laboratory at Baylor College of Medicine (now at Stanford) in 2015 by neuroscientists and technologists Dr. David Eagleman (Baylor College of Medicine/Stanford) and Dr. Yael Katz, BrainCheck enables physicians to accurately assess cognitive function and deliver cognitive care at scale. The platform is currently used by hundreds of clinical practices and over 40,000 individuals.
Through a combination of assessments, screeners, workflows and clinical decision support algorithms, the platform enables physicians to provide a detailed, personalized care plan to the patient and caregiver at the point of care.